215 related articles for article (PubMed ID: 16519787)
1. Comment on European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy.
Latov N
J Peripher Nerv Syst; 2006 Mar; 11(1):88-9; author reply 90-1. PubMed ID: 16519787
[No Abstract] [Full Text] [Related]
2. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
Joint Task Force of the EFNS and the PNS
J Peripher Nerv Syst; 2005 Sep; 10(3):220-8. PubMed ID: 16221283
[TBL] [Abstract][Full Text] [Related]
3. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--First Revision.
Joint Task Force of the EFNS and the PNS
J Peripher Nerv Syst; 2010 Mar; 15(1):1-9. PubMed ID: 20433600
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammatory demyelinating polyneuropathy.
Köller H; Kieseier BC; Jander S; Hartung HP
N Engl J Med; 2005 Mar; 352(13):1343-56. PubMed ID: 15800230
[No Abstract] [Full Text] [Related]
5. What is the best initial treatment for childhood chronic inflammatory demyelinating polyneuropathy: corticosteroids or intravenous immunoglobulin?
Sladky JT
Muscle Nerve; 2008 Dec; 38(6):1638-43. PubMed ID: 19016535
[No Abstract] [Full Text] [Related]
6. Treatment of chronic immune-mediated neuropathies: chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, and the Lewis-Sumner syndrome.
Sederholm BH
Semin Neurol; 2010 Sep; 30(4):443-56. PubMed ID: 20941678
[TBL] [Abstract][Full Text] [Related]
7. [Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy].
Nogués MA; Varela FJ; Seminario G; Insúa MC; Bezrodnik L
Medicina (B Aires); 2016; 76(1):36-9. PubMed ID: 26826992
[TBL] [Abstract][Full Text] [Related]
8. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision.
Van den Bergh PY; Hadden RD; Bouche P; Cornblath DR; Hahn A; Illa I; Koski CL; Léger JM; Nobile-Orazio E; Pollard J; Sommer C; van Doorn PA; van Schaik IN; ;
Eur J Neurol; 2010 Mar; 17(3):356-63. PubMed ID: 20456730
[TBL] [Abstract][Full Text] [Related]
9. Clinical condition of chronic inflammatory demyelinating polyneuropathy (CIDP).
Phillips LH
Muscle Nerve; 2009 Apr; 39(4):v-vii. PubMed ID: 19418620
[No Abstract] [Full Text] [Related]
10. Chronic inflammatory demyelinating polyneuropathy: a treatment protocol proposal.
Odaka M
Expert Rev Neurother; 2006 Mar; 6(3):365-79. PubMed ID: 16533141
[TBL] [Abstract][Full Text] [Related]
11. Initial treatment of childhood chronic inflammatory demyelinating polyradiculoneuropathy.
Teasley JE
Muscle Nerve; 2008 Dec; 38(6):1640-3. PubMed ID: 19125447
[No Abstract] [Full Text] [Related]
12. Peripheral nerve disorders.
Younger DS
Prim Care; 2004 Mar; 31(1):67-83. PubMed ID: 15110159
[No Abstract] [Full Text] [Related]
13. MNGIE neuropathy: five cases mimicking chronic inflammatory demyelinating polyneuropathy.
Bedlack RS; Vu T; Hammans S; Sparr SA; Myers B; Morgenlander J; Hirano M
Muscle Nerve; 2004 Mar; 29(3):364-8. PubMed ID: 14981734
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin (IVIG) in the treatment of chronic demyelinating polyradiculoneuropathy.
Van den Bergh PY
Acta Neurol Belg; 2001 Sep; 101(3):147-51. PubMed ID: 11817262
[No Abstract] [Full Text] [Related]
15. Intravenous immunoglobulin: a first-line treatment in CIDP?
Vermeulen M
Lancet Neurol; 2008 Feb; 7(2):115-6. PubMed ID: 18178526
[No Abstract] [Full Text] [Related]
16. The treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Kissel JT
Semin Neurol; 2003 Jun; 23(2):169-80. PubMed ID: 12894382
[TBL] [Abstract][Full Text] [Related]
17. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
Joint Task Force of the EFNS and the PNS
J Peripher Nerv Syst; 2006 Mar; 11(1):9-19. PubMed ID: 16519778
[TBL] [Abstract][Full Text] [Related]
18. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
Hughes RA; Bouche P; Cornblath DR; Evers E; Hadden RD; Hahn A; Illa I; Koski CL; Léger JM; Nobile-Orazio E; Pollard J; Sommer C; Van den Bergh P; van Doorn PA; van Schaik IN
Eur J Neurol; 2006 Apr; 13(4):326-32. PubMed ID: 16643309
[TBL] [Abstract][Full Text] [Related]
19. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Bunschoten C; Jacobs BC; Van den Bergh PYK; Cornblath DR; van Doorn PA
Lancet Neurol; 2019 Aug; 18(8):784-794. PubMed ID: 31076244
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus without systemic activity.
Calixto OJ; Poveda S; Meneses-Toro MA; Vera-Parra EC; Romero-Sánchez C; Guzman Molano LF; Bello-Gualtero JM
Lupus; 2023 Aug; 32(9):1123-1125. PubMed ID: 37369195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
